<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPLs) are a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of immunoglobulins that have been related with alterations in blood coagulability in recent years </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with elevated titers of these antibodies have a high probability to develop thrombotic events, including cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> (CI) </plain></SENT>
<SENT sid="2" pm="."><plain>The tests currently used to detect these antibodies are the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and ELISA for anticardiolipin antibodies which have a larger proportion of positivity among young patients with CI </plain></SENT>
<SENT sid="3" pm="."><plain>In our study we tested 66 patients with cerebral <z:mpath ids='MPATH_124'>infarcts</z:mpath> whose ages ranged from 15 to 40 years for the presence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and anticardiolipin antibodies </plain></SENT>
<SENT sid="4" pm="."><plain>The results showed that eleven (16.65%) patients were positive for aPLs and three (4.55%) of them fulfilled the diagnostic criteria for <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>These data point out to the importance of investigating aPLs in young patients with CI and its high prevalence in this group compared with healthy population </plain></SENT>
</text></document>